期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ANGIOGENESIS LetPub Score 7.7
50 ratings
Rate
Reputation 8.7 Influence 7.0 Speed 6.9 | ||||||||||||||||||||||||
期刊簡稱 | ANGIOGENESIS | ||||||||||||||||||||||||
ISSN | 0969-6970 | ||||||||||||||||||||||||
E-ISSN | 1573-7209 | ||||||||||||||||||||||||
h-index | 80 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 12.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/10456 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/agen | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer Netherlands | ||||||||||||||||||||||||
主題領域 | PERIPHERAL VASCULAR DISEASE | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||||||
每年文章數 | 27每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 56.48% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-6970%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[ANGIOGENESIS] 的評論 | 撰寫評論 |
作者: 寂灭湘灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-19 16:55:24 評論於 It has been almost two weeks since I submitted my manuscript. The status is peer review, so does it mean it's under review?(0) 讚! | 寂灭湘灵 |
作者: 水桥金钟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-02 17:18:20 評論於 It's been three days since I submitted my article and it's already showing as under peer review. Is it still in the hands of the editor?(0) 讚! | 水桥金钟 |
作者: 空灵紫玉 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-10-15 18:59:13 評論於 A bit confused about the situation. Submitted on the 29th, entered peer review on the 3rd, rejected on the 15th, but no feedback was provided(0) 讚! | 空灵紫玉 |
作者: 小怪兽123488 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2022-04-09 20:59:32 評論於 The submission took one week to reach the editor's hands, and it took the editor 16 days to decide whether to send it for review or reject it. It is indeed a bit slow. Editorial decision: Reject without review On 09 Apr, 2022 Editor assigned On 24 Mar, 2022 First submitted to Angiogenesis On 18 Mar, 2022(1) 讚! | 小怪兽123488 |
作者: 气甲可昕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-07 12:56:49 評論於 It takes one week for the submission to reach the editor. The editor then has 16 days to decide whether to send it for review or reject it, which is a bit slow(0) 讚! | 气甲可昕 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:25:21 評論於 Authors need to objectively assess whether the quality of their research work matches the level of the selected journal. Top journals have high requirements for the originality of manuscripts. The acceptance rate of top journals like Nature is less than 10%, with the majority of manuscripts being rejected at the editorial level(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:14:46 評論於 Please translate the following paragraph into English and Japanese, and label them as ":" and ":"(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 16:07:30 評論於 How many suitable alternative journals are generally chosen for each journal gradient?(0) 讚! | 北国博达 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:51:17 評論於 Can I submit my research directly to top journals like Nature or Science? Will they provide feedback?(0) 讚! | 平原文波 |
作者: 是陶然吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-26 21:58:31 評論於 In 2019, I thought my article was a 5 out of 10, which was fairly good. Looking back at previous years' articles, I felt that I was more than prepared. Coming into 2020, I gave it a 9 out of 10, because the direction was more aligned (researching angiogenesis regulation functions of protein, with animal models). So I still had confidence (at least enough to submit for review). However, the template rejected the submission, without even sending it for review!(0) 讚! | 是陶然吖 |
作者: 龙鳞昭懿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-10 09:32:44 評論於 How? Has anyone submitted this magazine? It has been in the hands of the editor for a week, why hasn't it been reviewed yet? If you want to reject it, do it quickly(0) 讚! | 龙鳞昭懿 |
作者: 璃沙子丹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-15 21:05:58 評論於 How are you? It's been over a month, any news?(0) 讚! | 璃沙子丹 |
作者: 魔都琛瑞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-02 10:06:46 評論於 Has anyone submitted this magazine before? It has been with the editor for a week, why hasn't it been sent for review yet? If you want to reject it, please do it quickly(0) 讚! | 魔都琛瑞 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 15:48:09 評論於 Passing the 5-point mark is worth celebrating. Next year, we will aim higher. Passing the 6-point mark will be even more special(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-18 20:16:05 評論於 Got it wrong, I think it's around 7 points(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us